Endometrial carcinoma is one of the most frequently diagnosed
cancers in females. Long non-coding RNAs (lncRNAs) have been associated with
cancer; its role in
endometrial carcinoma is an emerging area of research. In this article,
lncRNA TDRG1 expression in human
endometrial carcinoma tissues and normal endometrial tissues was quantified by qRT-PCR.
LncRNA TDRG1 was overexpressed or knocked-down in neither HEC-1B nor Ishikawa
endometrial carcinoma cells, respectively, to assess cellular phenotype and expression of related molecules. Our results showed that
lncRNA TDRG1 was significantly overexpressed in
endometrial carcinoma tissues. Overexpression of
lncRNA TDRG1 promoted
endometrial carcinoma cell viability, invasion and migratory ability, inhibited apoptosis, and upregulated
VEGF-A, PI3K, Bcl-2, MMP2 and
survivin; knockdown of
lncRNA TDRG1 had the opposite effects.
LncRNA TDRG1 overexpression increased tumorigenicity in vivo and was associated with the upregulation of
VEGF-A.
RNA binding protein immunoprecipitation (RIP) assays confirmed that
lncRNA TDRG1 directly binds to
VEGF-A protein. Furthermore, knockdown of VEGFA in
lncRNA TDRG1-overexpressing
endometrial carcinoma cells reversed the effects of
lncRNA TDRG1 on cell proliferation, invasion, migration and apoptosis. In conclusion,
lncRNA TDRG1 may promote
endometrial carcinoma cell proliferation and invasion by positively targeting
VEGF-A and modulating relative genes.